Amlodipine Besylate Tablet
Product Images NDC 42291-025

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 42291-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000 (025 10)

Label for Amlodipine Besylate Tablets USP 2.5 mg by AvKARE, featuring the AvKARE logo and NDC 42291-025-10. The label indicates 1000 oral tablets with a strength of 2.5 mg each. Directions advise dispensing with the patient information leaflet, and include storage instructions and safety precautions.*

FDA Label Image

1000 (026 10)

Label for Amlodipine Besylate Tablets, USP 5 mg by AvKARE. The label indicates 1000 tablets in the package, oral tablet form, and Rx only. It instructs to dispense with an attached patient information leaflet and provides storage instructions along with manufacturer information.*

FDA Label Image

1000 (027 10)

Amlodipine Besylate Tablets USP 10 mg oral tablets label by AvKARE. The label indicates 1000 tablets in the package and states Rx Only. It includes dispensing instructions, storage conditions, and cautions to keep the medication out of children's reach. Barcode and QR code are present.*

FDA Label Image

90 (027 90)

Label for Amlodipine Besylate Tablets, USP 10 mg by AvKARE. The oral tablet package contains 90 tablets. It includes pharmacy dispensing instructions and storage guidelines, with warnings to keep the medication out of reach of children, and states the manufacturer details and website.*

FDA Label Image

Chemical Structure (Image 1)

Chemical structure diagram of Amlodipine Besylate, depicting the molecular arrangement including aromatic rings, chlorine, ester groups, and an aminoethyl side chain. The molecular formula C20H25ClN2O5S is shown beneath the structure.*

FDA Label Image

\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig01.jpg)

A line graph comparing event rates over 24 months between two groups labeled Placebo and Amlodipine. The graph includes statistical data such as a p-value of 0.003, a hazard ratio of 0.691, and a 95% confidence interval from 0.54 to 0.88. The x-axis represents time in months, and the y-axis represents event rate.*

FDA Label Image

\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig02.jpg)

A hazard ratio forest plot evaluating the effect of Amlodipine across various patient subgroups including age, gender, baseline sitting systolic blood pressure, baseline vessel disease, and PCI-stent strata. The plot presents hazard ratios with 95% confidence intervals comparing favorability between Amlodipine and placebo in a study population of 1,318 patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.